TGY2IT
CHRS icon

Timothy G. Youngquist 2020 Irrevocable Trust’s Coherus Oncology CHRS Stock Holding History

Timothy G. Youngquist 2020 Irrevocable Trust’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25K Sell
200,000
-260,000
-57% -$424K ﹤0.01% 86
2026
Q1 		$75K Buy
+460,000
New +$817K 0.03% 184

Other funds holding CHRS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TWP
Tyche Wealth Partners Plano, Texas $712M AUM 29.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Timothy G. Youngquist 2020 Irrevocable Trust's CHRS Position: Q2 2026 in Review

Timothy G. Youngquist 2020 Irrevocable Trust increased its Coherus Oncology (CHRS) stake by 6.2% in Q2 2026, buying an estimated $1.24M and bringing the position to 13,050,623 shares worth $18.3M. The position accounts for 3.58% of the portfolio, ranked #3.

Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in CHRS in Q4 2025 and has held it in 3 quarters since. The position peaked at $20.8M in Q1 2026. 52 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • Timothy G. Youngquist 2020 Irrevocable Trust held 13,050,623 shares of Coherus Oncology worth $18.3M as of Q2 2026.
  • Timothy G. Youngquist 2020 Irrevocable Trust bought 759,823 Coherus Oncology shares in Q2 2026, an estimated $1.24M.
  • Coherus Oncology made up 3.58% of Timothy G. Youngquist 2020 Irrevocable Trust's portfolio in Q2 2026, its #3 holding.
  • Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in Coherus Oncology in Q4 2025 and has held it in 3 quarters since.
  • Timothy G. Youngquist 2020 Irrevocable Trust's Coherus Oncology position peaked at $20.8M in Q1 2026.
  • 52 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Timothy G. Youngquist 2020 Irrevocable Trust's 13F filing for Q2 2026, filed 7 Aug 2026.